Relationship between 1-, 3-, and 6-Month Gingival Bleeding Outcomes

Area of Science:

• Oral health research
• Periodontal disease management
• Clinical trial methodology

Background:

• Systematic reviews indicate consistent antigingivitis effects of stannous fluoride (SnF2) dentifrice at 3- and 6-month intervals.
• The relationship between early (1-month) and later (3- and 6-month) gingivitis responses to SnF2 dentifrice has not been previously investigated.

Purpose of the Study:

• To analyze the relationship between 1-, 3-, and 6-month gingival bleeding outcomes in clinical studies.
• To determine if early gingivitis assessments can predict longer-term efficacy of SnF2 dentifrice.

Main Methods:

• Pooled analysis of randomized, double-blinded, controlled clinical trials (1995-2022) comparing 0.454% SnF2 dentifrice to negative controls.
• Primary endpoint: number of bleeding sites (LSGI or Gingival Bleeding Index).
• Inclusion criteria: studies with 3-month assessments and at least 1- or 6-month assessments.

Main Results:

• Gingival bleeding efficacy significantly increased from 1 to 3 months (P < 0.0001) and plateaued from 3 to 6 months (P = 0.007).
• Bleeding reduction established by 1 month was maintained through 3 and 6 months (R² = 0.857).
• Gingival bleeding and gingivitis efficacy (LSGI) were highly correlated (R² = 0.874).

Conclusions:

• A clear relationship exists between 1-, 3-, and 6-month gingival bleeding outcomes with SnF2 dentifrice.
• Antigingivitis efficacy evaluations can be reliably conducted as early as 1 month, correlating with 3- and 6-month results.
• 1-month study durations are viable for knowledge acquisition, improving research efficiency and informing clinical practice.